Brašić, J.R.; Nandi, A.; Russell, D.S.; Jennings, D.; Barret, O.; Martin, S.D.; Slifer, K.; Sedlak, T.; Seibyl, J.P.; Wong, D.F.;
et al. Cerebral Expression of Metabotropic Glutamate Receptor Subtype 5 in Idiopathic Autism Spectrum Disorder and Fragile X Syndrome: A Pilot Study. Int. J. Mol. Sci. 2021, 22, 2863.
https://doi.org/10.3390/ijms22062863
AMA Style
Brašić JR, Nandi A, Russell DS, Jennings D, Barret O, Martin SD, Slifer K, Sedlak T, Seibyl JP, Wong DF,
et al. Cerebral Expression of Metabotropic Glutamate Receptor Subtype 5 in Idiopathic Autism Spectrum Disorder and Fragile X Syndrome: A Pilot Study. International Journal of Molecular Sciences. 2021; 22(6):2863.
https://doi.org/10.3390/ijms22062863
Chicago/Turabian Style
Brašić, James Robert, Ayon Nandi, David S. Russell, Danna Jennings, Olivier Barret, Samuel D. Martin, Keith Slifer, Thomas Sedlak, John P. Seibyl, Dean F. Wong,
and et al. 2021. "Cerebral Expression of Metabotropic Glutamate Receptor Subtype 5 in Idiopathic Autism Spectrum Disorder and Fragile X Syndrome: A Pilot Study" International Journal of Molecular Sciences 22, no. 6: 2863.
https://doi.org/10.3390/ijms22062863
APA Style
Brašić, J. R., Nandi, A., Russell, D. S., Jennings, D., Barret, O., Martin, S. D., Slifer, K., Sedlak, T., Seibyl, J. P., Wong, D. F., & Budimirovic, D. B.
(2021). Cerebral Expression of Metabotropic Glutamate Receptor Subtype 5 in Idiopathic Autism Spectrum Disorder and Fragile X Syndrome: A Pilot Study. International Journal of Molecular Sciences, 22(6), 2863.
https://doi.org/10.3390/ijms22062863
